×
About 36,746 results

ALLMedicine™ Acute Coronary Syndrome Center

Research & Reviews  17,471 results

Decline of emergency admissions for cardiovascular and cerebrovascular events after the...
https://doi.org/10.1007/s00392-020-01688-9
Clinical Research in Cardiology : Official Journal of the German Cardiac Society; Schwarz V, Mahfoud F et. al.

Aug 3rd, 2020 - The spread of the novel coronavirus SARS-CoV-2 and the guidance from authorities for social distancing and media reporting lead to significant uncertainty in Germany. Concerns have been expressed regarding the underdiagnosing of harmful diseases. ...

Chromogranin-A serum levels in patients with takotsubo syndrome and ST elevation acute ...
https://doi.org/10.1016/j.ijcard.2020.07.040
International Journal of Cardiology; Tarantino N, Santoro F et. al.

Aug 2nd, 2020 - Sympathergic hyperactivity is considered one of the main trigger precipitating takotsubo syndrome (TTS). Chromogranin-A (CgA), a prognostic biomarker of sympatho-adrenal activation, is remarkably high in acute coronary syndrome (ACS) and heart fai...

Percutaneous complete revascularization strategies using sirolimus-eluting biodegradabl...
https://doi.org/10.1016/j.ahj.2020.06.006
American Heart Journal; den Dekker WK, Van Mieghem NM et. al.

Aug 2nd, 2020 - Complete revascularization in patients with an acute coronary syndrome and multivessel disease is superior compared to culprit-only treatment. However, it is unknown whether direct complete or staged complete revascularization should be pursued. T...

Cannabis and acute myocardial infarction.
https://doi.org/10.1097/01.JAA.0000668804.51594.03
JAAPA : Official Journal of the American Academy of Physician Assistants; Emanuel T, Varney SM et. al.

Aug 2nd, 2020 - Marijuana is one of the most commonly consumed psychotropic drugs in the world. It has been associated with adverse cardiovascular reactions including acute coronary syndrome, but this information is not widely known among emergency medicine clini...

Extended antiplatelet therapy with clopidogrel alone versus clopidogrel plus aspirin af...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7346838
American Heart Journal; Li Y, Jing Q et. al.

Aug 2nd, 2020 - Dual antiplatelet therapy with aspirin and a P2Y12 inhibitor is the cornerstone for prevention ischemic events in patients with acute coronary syndromes (ACS) and undergoing percutaneous coronary intervention. However, the optimal antiplatelet str...

see more →

Guidelines  41 results

EAPCI Position Statement on Invasive Management of Acute Coronary Syndromes during the ...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7239193
European Heart Journal; Chieffo A, Stefanini GG et. al.

May 14th, 2020 - The coronavirus disease 2019 (COVID-19) pandemic poses an unprecedented challenge to healthcare worldwide. The infection can be life threatening and require intensive care treatment. The transmission of the disease poses a risk to both patients an...

ACR Appropriateness Criteria® Chest Pain-Possible Acute Coronary Syndrome.
https://doi.org/10.1016/j.jacr.2020.01.027
Journal of the American College of Radiology : JACR; , Batlle JC et. al.

May 5th, 2020 - Chest pain is a frequent cause for emergency department visits and inpatient evaluation, with particular concern for acute coronary syndrome as an etiology, since cardiovascular disease is the leading cause of death in the United States. Although ...

Taking the Air Out of Oxygen Supplementation in Individuals With Diabetes and Acute Coronary Syndromes
https://care.diabetesjournals.org/content/42/11/2019
Diabetes Care;

Aug 31st, 2019 - Oxygen supplementation has been a cornerstone in the initial treatment of individuals with acute coronary syndrome. While consensus for oxygen supplementation exists for patients with hypoxia, oxygen supplementation has also been routinely used in...

Intensive Lipid Lowering in Elderly Patients
https://jamanetwork.com/journals/jamacardiology/article-abstract/2738100
JAMA Cardiology; Gotto,A.

Jul 16th, 2019 - In this issue of JAMA Cardiology, a prespecified post hoc analysis of the Improved Reduction of Outcomes: Vytorin Efficacy International Trial (IMPROVE-IT) examines the effect of age on higher-intensity lipid lowering in patients after an acute co...

Depression Following Acute Coronary Syndrome Events: Screening and Treatment Guidelines from the AAFP
https://www.aafp.org/afp/2019/0615/od2.html
American Family Physician;

Jun 14th, 2019 - Purpose: To review the evidence and provide clinical recommendations for the screening and treatment of depression in patients who have had a recent acute coronary syndrome event. Methods: This guideline is based on a systematic review of randomi...

see more →

Drugs  253 results see all →

Clinicaltrials.gov  18,145 results

Decline of emergency admissions for cardiovascular and cerebrovascular events after the...
https://doi.org/10.1007/s00392-020-01688-9
Clinical Research in Cardiology : Official Journal of the German Cardiac Society; Schwarz V, Mahfoud F et. al.

Aug 3rd, 2020 - The spread of the novel coronavirus SARS-CoV-2 and the guidance from authorities for social distancing and media reporting lead to significant uncertainty in Germany. Concerns have been expressed regarding the underdiagnosing of harmful diseases. ...

Chromogranin-A serum levels in patients with takotsubo syndrome and ST elevation acute ...
https://doi.org/10.1016/j.ijcard.2020.07.040
International Journal of Cardiology; Tarantino N, Santoro F et. al.

Aug 2nd, 2020 - Sympathergic hyperactivity is considered one of the main trigger precipitating takotsubo syndrome (TTS). Chromogranin-A (CgA), a prognostic biomarker of sympatho-adrenal activation, is remarkably high in acute coronary syndrome (ACS) and heart fai...

Percutaneous complete revascularization strategies using sirolimus-eluting biodegradabl...
https://doi.org/10.1016/j.ahj.2020.06.006
American Heart Journal; den Dekker WK, Van Mieghem NM et. al.

Aug 2nd, 2020 - Complete revascularization in patients with an acute coronary syndrome and multivessel disease is superior compared to culprit-only treatment. However, it is unknown whether direct complete or staged complete revascularization should be pursued. T...

Cannabis and acute myocardial infarction.
https://doi.org/10.1097/01.JAA.0000668804.51594.03
JAAPA : Official Journal of the American Academy of Physician Assistants; Emanuel T, Varney SM et. al.

Aug 2nd, 2020 - Marijuana is one of the most commonly consumed psychotropic drugs in the world. It has been associated with adverse cardiovascular reactions including acute coronary syndrome, but this information is not widely known among emergency medicine clini...

Extended antiplatelet therapy with clopidogrel alone versus clopidogrel plus aspirin af...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7346838
American Heart Journal; Li Y, Jing Q et. al.

Aug 2nd, 2020 - Dual antiplatelet therapy with aspirin and a P2Y12 inhibitor is the cornerstone for prevention ischemic events in patients with acute coronary syndromes (ACS) and undergoing percutaneous coronary intervention. However, the optimal antiplatelet str...

see more →

News  809 results

Second trial supports ticagrelor alone in ACS after PCI: TICO
https://www.mdedge.com/cardiology/article/219887/acute-coronary-syndromes/second-trial-supports-ticagrelor-alone-acs-after?channel=53
Sue Hughes

Mar 31st, 2020 - A second trial has shown benefit of stopping aspirin 3 months after stenting and continuing solely with ticagrelor monotherapy. The Ticagrelor With or Without Aspirin in Acute Coronary Syndrome After PCI (TICO) study shows very similar results as.

AUGUSTUS: Apixaban surpassed warfarin despite prior stroke or thromboembolism
https://www.mdedge.com/emergencymedicine/article/218617/arrhythmias-ep/augustus-apixaban-surpassed-warfarin-despite-prior?channel=53
Mitchel L. Zoler

Mar 7th, 2020 - LOS ANGELES – The edge that the direct-acting oral anticoagulant apixaban (Eliquis) has over warfarin for safely preventing ischemic events in patients with atrial fibrillation and either a recent acute coronary syndrome event or a recent percutan.

Dual vs Triple Therapy Following ACS or PCI in Patients with Atrial Fibrillation
https://www.mdedge.com/jcomjournal/article/212537/cardiology/dual-vs-triple-therapy-following-acs-or-pci-patients-atrial/page/0/2?channel=41021

Dec 4th, 2019 - Applications for Clinical Practice In patients with atrial fibrillation and a recent acute coronary syndrome or PCI treated with a P2Y12 inhibitor, dual therapy with a P2Y12 inhibitor and DOAC should be favored over a regimen that includes a vitam.

The TWILIGHT of aspirin post-PCI for ACS?
https://www.mdedge.com/internalmedicine/article/212513/interventional-cardiology-surgery/twilight-aspirin-post-pci-acs?channel=39313
Bruce Jancin

Nov 18th, 2019 - PHILADELPHIA – Downshifting to ticagrelor monotherapy after just 3 months of dual antiplatelet therapy is a winning strategy in high-risk patients who’ve undergone PCI for non-ST-elevation acute coronary syndrome, Usman Baber, MD, reported at the.

Starting PCSK9 inhibitor in acute-phase ACS under study
https://www.mdedge.com/internalmedicine/article/210923/acute-coronary-syndromes/starting-pcsk9-inhibitor-acute-phase-acs?channel=194
Bruce Jancin

Oct 25th, 2019 - PARIS – The first-ever randomized trial of in-hospital initiation of a PCSK9 inhibitor on top of guideline-recommended high-intensity statin therapy in the very-high-risk acute phase of an acute coronary syndrome (ACS) safely resulted in dramatica.

see more →

Patient Education  27 results see all →